ADRs via smartphone
September 9, 2014
THE Medicines and Healthcare
products Regulatory Agency
(MHRA) is leading a consortium of
organisations, including European
medicines regulators, academics
and the pharmaceutical industry, in
a three year project to develop new
ways of gathering information on
suspected adverse drug reactions
(ADRs).
Dubbed WEB-RADR, the project
is in response to the broad uptake
of smartphones, apps, and social
media for discussing issues with
medicines and health.
The project working group
would develop a mobile app for
healthcare professionals and the
public to report suspected ADRs to
national EU regulators, MHRA said.
In addition, the potential for
publicly available social media data
for identifying potential drug safety
issues would be explored.
WEB-RADR would also examine
the value of these new tools for
monitoring drug safety and helping
to develop recommendations for
medicines regulators, said MHRA.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Sep 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Sep 14
